跳至主要内容
临床试验/EUCTR2021-001571-17-FR
EUCTR2021-001571-17-FR招募中1 期

/A - DEXHIA

CHU de Nantes0 个研究点目标入组 106 人开始时间: 2021年5月11日最近更新:
相关药物

试验速览

阶段
1 期
状态
招募中
发起方
CHU de Nantes
入组人数
106

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • - Patients with sciatica of disc origin (radio-clinical concordance on MRI or CT) postero-lateral
  • - Duration of evolution greater than 3 weeks despite analgesic / NSAID treatment, and less than 3 months
  • - EVA sciatic pain > 4/10
  • - Oswestry greater than or equal to 30 at inclusion
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range 90
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range 16

排除标准

  • - Signs or risks of infection, in particular signs of viral infection (perform a screening PCR if there is any doubt that it is still a pandemic period when the protocol is set up)
  • - Poor local skin condition
  • - Anticoagulation with VKA or anti-Xa, or haemorrhagic disease (authorised antiaggregants)*.
  • - Neurological deficit < 3/5 or signs of cauda equina irritation
  • - Tarlov's cyst or low dural sac below S4
  • - Allergy to Lidocaine, Dexamethasone or Sulphites
  • - Spinal infiltration in the previous 3 months
  • - Patient with bilateral sciatica
  • - Patient with sciatica of arthritic origin
  • - Patient with chronic respiratory failure

研究者

发起方
CHU de Nantes

相似试验